Enovis Corp (LTS:0I1B)
$ 48.35 -0.10705 (-0.22%) Market Cap: 2.73 Bil Enterprise Value: 4.11 Bil PE Ratio: 0 PB Ratio: 0.82 GF Score: 68/100

Colfax Corp at Stifel Virtual Healthcare Conference Transcript

Nov 18, 2020 / 01:40PM GMT
Release Date Price: $67.97
Nathan Hardie Jones
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst

Good morning, everyone. I'm Nathan Jones. I cover Colfax at Stifel, and I'm very pleased to have Colfax CEO, Matthew Trerotola, with us this morning, along with Mike Macek from Investor Relations.

(Operator Instructions) We're going to start this session with a presentation from Matt. So Matt, over to you.

Matthew L. Trerotola
Colfax Corporation - President, CEO & Director

Great. Thanks, Nathan, and good morning, everyone. It's great to be with you here. Virtually, if you go through the disclosure to Page 3, there's just a summary of the key points that I'm going to hit in 10 or 15 minutes and really going to spend a little extra time on the MedTech platform as I work through these points.

The next page, Page 4, talks about our strategy for our company. We were founded by Mitch and Steve Rales a decade or so after they founded Danaher. And we've been driving a compounding strategy for value creation. We're a diversified -- I'll talk about our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot